• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非编码RNA在肝细胞癌肿瘤免疫微环境中的作用

Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma.

作者信息

Lv Yue, Wang Zhen, Yuan Kefei

机构信息

Department of Liver Surgery & Liver Transplantation, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center of Biotherapy, Chengdu, Sichuan, China.

Laboratory of Liver Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

出版信息

J Clin Transl Hepatol. 2023 Jun 28;11(3):682-694. doi: 10.14218/JCTH.2022.00412. Epub 2023 Jan 19.

DOI:10.14218/JCTH.2022.00412
PMID:36969884
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10037505/
Abstract

Hepatocellular carcinoma (HCC) is one of the most prevalent malignancies. It has high mortality and poor clinical outcomes, but the molecular mechanisms in the pathogenesis of HCC are not understood. The tumor immune microenvironment (TIME) is a highly intricate system with distinct populations of innate and adaptive immune cells, as well as other stromal cells. They interact and evolve with tumor cells to influence tumor growth, migration, invasion, immune evasion, and response to therapy. Emerging evidence has shown noncoding RNAs (ncRNAs) are prominent regulators of TIME in HCC. In this review, we elaborate on the functions and molecular mechanisms of ncRNAs in remodeling TIME of HCC and discuss their diagnostic and therapeutic potential for HCC treatment.

摘要

肝细胞癌(HCC)是最常见的恶性肿瘤之一。它具有高死亡率和较差的临床预后,但HCC发病机制中的分子机制尚不清楚。肿瘤免疫微环境(TIME)是一个高度复杂的系统,由不同群体的先天性和适应性免疫细胞以及其他基质细胞组成。它们与肿瘤细胞相互作用并共同进化,以影响肿瘤的生长、迁移、侵袭、免疫逃逸及对治疗的反应。新出现的证据表明,非编码RNA(ncRNAs)是HCC中TIME的重要调节因子。在本综述中,我们阐述了ncRNAs在重塑HCC的TIME中的功能和分子机制,并讨论了它们在HCC治疗中的诊断和治疗潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47e/10037505/b8e6a396636f/JCTH-11-682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47e/10037505/a14437921a0c/JCTH-11-682-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47e/10037505/b8e6a396636f/JCTH-11-682-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47e/10037505/a14437921a0c/JCTH-11-682-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d47e/10037505/b8e6a396636f/JCTH-11-682-g002.jpg

相似文献

1
Role of Noncoding RNAs in the Tumor Immune Microenvironment of Hepatocellular Carcinoma.非编码RNA在肝细胞癌肿瘤免疫微环境中的作用
J Clin Transl Hepatol. 2023 Jun 28;11(3):682-694. doi: 10.14218/JCTH.2022.00412. Epub 2023 Jan 19.
2
The Underlying Mechanisms of Noncoding RNAs in the Chemoresistance of Hepatocellular Carcinoma.非编码RNA在肝细胞癌化疗耐药中的潜在机制
Mol Ther Nucleic Acids. 2020 Sep 4;21:13-27. doi: 10.1016/j.omtn.2020.05.011. Epub 2020 May 15.
3
Noncoding RNA-mediated macrophage and cancer cell crosstalk in hepatocellular carcinoma.非编码RNA介导的肝细胞癌中巨噬细胞与癌细胞的串扰
Mol Ther Oncolytics. 2022 Mar 16;25:98-120. doi: 10.1016/j.omto.2022.03.002. eCollection 2022 Jun 16.
4
The Mechanism Underlying the ncRNA Dysregulation Pattern in Hepatocellular Carcinoma and Its Tumor Microenvironment.肝细胞癌中 ncRNA 失调模式及其肿瘤微环境的作用机制。
Front Immunol. 2022 Feb 23;13:847728. doi: 10.3389/fimmu.2022.847728. eCollection 2022.
5
The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma.非编码 RNA 在肝细胞癌代谢重编程调控中的作用及其机制。
Int J Cancer. 2022 Aug 1;151(3):337-347. doi: 10.1002/ijc.34040. Epub 2022 May 11.
6
Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects.肝细胞癌中非编码RNA的治疗靶点:最新进展与未来展望
Oncol Lett. 2018 Mar;15(3):3395-3402. doi: 10.3892/ol.2018.7758. Epub 2018 Jan 9.
7
Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients.鉴定与肿瘤微环境相关的新型长链非编码RNA以确定肝细胞癌患者的预后及对免疫治疗的反应
Front Mol Biosci. 2021 Dec 24;8:781307. doi: 10.3389/fmolb.2021.781307. eCollection 2021.
8
Molecular mechanisms of circular RNAs, transforming growth factor-β, and long noncoding RNAs in hepatocellular carcinoma.环状 RNA、转化生长因子-β和长链非编码 RNA 在肝细胞癌中的分子机制。
Cancer Med. 2019 Nov;8(15):6684-6699. doi: 10.1002/cam4.2553. Epub 2019 Sep 15.
9
Non-coding RNAs in hepatocellular carcinoma: Insights into regulatory mechanisms, clinical significance, and therapeutic potential.非编码 RNA 在肝细胞癌中的作用:调控机制、临床意义及治疗潜能的深入探讨。
Front Immunol. 2022 Oct 10;13:985815. doi: 10.3389/fimmu.2022.985815. eCollection 2022.
10
The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.外泌体非编码RNA在肝细胞癌中的潜在作用
Front Oncol. 2022 Feb 24;12:790916. doi: 10.3389/fonc.2022.790916. eCollection 2022.

引用本文的文献

1
Ferroptosis rewired: ncRNA gatekeepers as pharmacological targets in hepatocellular carcinoma.铁死亡重编程:非编码RNA守门人作为肝细胞癌的药理学靶点
Naunyn Schmiedebergs Arch Pharmacol. 2025 Jul 7. doi: 10.1007/s00210-025-04404-4.
2
Construction and Validation of a T Cell Exhaustion-Related Prognostic Signature in Cholangiocarcinoma.胆管癌中T细胞耗竭相关预后标志物的构建与验证
Int J Genomics. 2025 Mar 10;2025:8823837. doi: 10.1155/ijog/8823837. eCollection 2025.
3
Regulation of immune-mediated chemoresistance in cancer by lncRNAs: an in-depth review of signaling pathways.

本文引用的文献

1
The LINC00261/MiR105-5p/SELL axis is involved in dysfunction of B cell and is associated with overall survival in hepatocellular carcinoma.LINC00261/miR-105-5p/SELL 轴参与 B 细胞功能障碍,并与肝癌患者的总生存率相关。
PeerJ. 2022 Jun 9;10:e12588. doi: 10.7717/peerj.12588. eCollection 2022.
2
Exosomal circGSE1 promotes immune escape of hepatocellular carcinoma by inducing the expansion of regulatory T cells.外泌体 circGSE1 通过诱导调节性 T 细胞扩增促进肝癌的免疫逃逸。
Cancer Sci. 2022 Jun;113(6):1968-1983. doi: 10.1111/cas.15365. Epub 2022 Apr 26.
3
MicroRNAs/LncRNAs Modulate MDSCs in Tumor Microenvironment.
长链非编码RNA对癌症中免疫介导的化疗耐药性的调控:信号通路深入综述
Naunyn Schmiedebergs Arch Pharmacol. 2025 Apr 9. doi: 10.1007/s00210-025-04081-3.
4
Non-coding RNAs: emerging biomarkers and therapeutic targets in cancer and inflammatory diseases.非编码RNA:癌症和炎症性疾病中新兴的生物标志物及治疗靶点
Front Oncol. 2025 Mar 10;15:1534862. doi: 10.3389/fonc.2025.1534862. eCollection 2025.
5
Identification and Validation of the Hsa_circ_0001726/miR-140-3p/KRAS Axis in Hepatocellular Carcinoma Based on Microarray Analyses and Experiments.基于微阵列分析和实验对肝细胞癌中hsa_circ_0001726/miR-140-3p/KRAS轴的鉴定与验证
J Clin Transl Hepatol. 2024 Nov 28;12(11):897-906. doi: 10.14218/JCTH.2024.00270. Epub 2024 Oct 21.
6
Treatment Options for Hepatocellular Carcinoma Using Immunotherapy: Present and Future.肝细胞癌免疫治疗的治疗选择:现状与未来。
J Clin Transl Hepatol. 2024 Apr 28;12(4):389-405. doi: 10.14218/JCTH.2023.00462. Epub 2024 Feb 28.
7
Immune Regulatory Networks and Therapy of γδ T Cells in Liver Cancer: Recent Trends and Advancements.肝癌中γδ T细胞的免疫调节网络与治疗:最新趋势与进展
J Clin Transl Hepatol. 2024 Mar 28;12(3):287-297. doi: 10.14218/JCTH.2023.00355. Epub 2024 Jan 8.
8
IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8 T Cells in the Tumor Microenvironment.IGF2BP3通过调节肿瘤微环境中巨噬细胞和CD8 T细胞的特性来促进肝细胞癌肿瘤生长。
J Clin Transl Hepatol. 2023 Nov 28;11(6):1308-1320. doi: 10.14218/JCTH.2023.00184. Epub 2023 Aug 1.
微小RNA/长链非编码RNA在肿瘤微环境中调节髓源性抑制细胞。
Front Oncol. 2022 Mar 14;12:772351. doi: 10.3389/fonc.2022.772351. eCollection 2022.
4
Pyroptosis-Related LncRNA Signature Predicts Prognosis and Is Associated With Immune Infiltration in Hepatocellular Carcinoma.焦亡相关长链非编码RNA特征预测肝细胞癌预后并与免疫浸润相关
Front Oncol. 2022 Mar 3;12:794034. doi: 10.3389/fonc.2022.794034. eCollection 2022.
5
The Potential Roles of Exosomal Non-Coding RNAs in Hepatocellular Carcinoma.外泌体非编码RNA在肝细胞癌中的潜在作用
Front Oncol. 2022 Feb 24;12:790916. doi: 10.3389/fonc.2022.790916. eCollection 2022.
6
The Role of Long Non-Coding RNAs in the Tumor Immune Microenvironment.长非编码 RNA 在肿瘤免疫微环境中的作用。
Front Immunol. 2022 Feb 9;13:851004. doi: 10.3389/fimmu.2022.851004. eCollection 2022.
7
Exosomal hsa_circ_0004658 derived from RBPJ overexpressed-macrophages inhibits hepatocellular carcinoma progression via miR-499b-5p/JAM3.外泌体 hsa_circ_0004658 来源于过表达 RBPJ 的巨噬细胞,通过 miR-499b-5p/JAM3 抑制肝癌进展。
Cell Death Dis. 2022 Jan 10;13(1):32. doi: 10.1038/s41419-021-04345-9.
8
hsa_circ_0003410 promotes hepatocellular carcinoma progression by increasing the ratio of M2/M1 macrophages through the miR-139-3p/CCL5 axis.hsa_circ_0003410 通过 miR-139-3p/CCL5 轴增加 M2/M1 巨噬细胞的比例促进肝细胞癌的进展。
Cancer Sci. 2022 Feb;113(2):634-647. doi: 10.1111/cas.15238. Epub 2021 Dec 22.
9
Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis.通过泛癌症分析鉴定的 lncRNA ASB16-AS1 的表达、预后价值和免疫浸润。
Bioengineered. 2021 Dec;12(2):10302-10318. doi: 10.1080/21655979.2021.1996054.
10
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.肿瘤微环境中癌症相关成纤维细胞与免疫细胞的串扰:新发现与未来展望。
Mol Cancer. 2021 Oct 11;20(1):131. doi: 10.1186/s12943-021-01428-1.